Sweeping tariffs on Mexico, China and Canada were imposed at midnight, March 4, with President Donald Trump stating in remarks at the White House that there would be no last-minute deals, The New York Times reported March 3.
Johnson & Johnson MedTech issued a recall for its Biosense Webster Varipulse Bi-Directional Ablation Catheter following reports of strokes and transient ischemic attacks in patients undergoing procedures with the device.
Boston Scientific has reached an agreement to acquire SoniVie, a medical device company developing the TIVUS Intravascular Ultrasound System, an investigational technology aimed at treating hypertension through renal artery denervation.
As the healthcare industry continues to embrace digital innovation, artificial intelligence continues to play an increasingly pivotal role in helping to optimize supply chain operations.
President Donald Trump confirmed that 25% tariffs on imports from Canada and Mexico, along with a 10% additional tariff on Chinese imports, will take effect March 4, according to a Feb. 27 post to Truth Social.
Since establishing its own group purchasing organization in 2018, Phoenix-based Banner Health has aimed to drive cost savings and improve supply chain efficiencies across its network.
Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas.
While President Donald Trump postponed proposed 25% tariffs against both China and Mexico, they are officially set to begin next week, according to a Feb. 25 report from CNBC.